These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 16375981)

  • 1. Fenretinide inhibits HIV infection by promoting viral endocytosis.
    Finnegan CM; Blumenthal R
    Antiviral Res; 2006 Feb; 69(2):116-23. PubMed ID: 16375981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clathrin, caveolae, and dynamin-independent endocytic pathway requiring free membrane cholesterol drives HIV-1 internalization and infection in polarized trophoblastic cells.
    Vidricaire G; Tremblay MJ
    J Mol Biol; 2007 May; 368(5):1267-83. PubMed ID: 17395200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of endosomal/lysosomal degradation increases the infectivity of human immunodeficiency virus.
    Fredericksen BL; Wei BL; Yao J; Luo T; Garcia JV
    J Virol; 2002 Nov; 76(22):11440-6. PubMed ID: 12388705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of the membrane-proximal tyrosine-based sorting signal of HIV-1 gp41 on viral infectivity depends on sequences within gp120.
    Day JR; Van Damme N; Guatelli JC
    Virology; 2006 Oct; 354(2):316-27. PubMed ID: 16905171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 Vpu inhibits accumulation of the envelope glycoprotein within clathrin-coated, Gag-containing endosomes.
    Van Damme N; Guatelli J
    Cell Microbiol; 2008 May; 10(5):1040-57. PubMed ID: 18076669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The endocytic pathway for human immunodeficiency virus infection.
    Pauza CD
    Adv Exp Med Biol; 1991; 300():111-38; discussion 139-44. PubMed ID: 1781341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceramide, a target for antiretroviral therapy.
    Finnegan CM; Rawat SS; Puri A; Wang JM; Ruscetti FW; Blumenthal R
    Proc Natl Acad Sci U S A; 2004 Oct; 101(43):15452-7. PubMed ID: 15489273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.
    BouHamdan M; Kulkosky J; Duan LX; Pomerantz RJ
    J Hum Virol; 2000; 3(1):6-15. PubMed ID: 10774802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocytic entry of HIV-1.
    Fackler OT; Peterlin BM
    Curr Biol; 2000 Aug; 10(16):1005-8. PubMed ID: 10985390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of HIV-1 endocytosis allows lipid mixing at the plasma membrane, but not complete fusion.
    de la Vega M; Marin M; Kondo N; Miyauchi K; Kim Y; Epand RF; Epand RM; Melikyan GB
    Retrovirology; 2011 Dec; 8():99. PubMed ID: 22145853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trans-infection but not infection from within endosomal compartments after cell-to-cell HIV-1 transfer to CD4+ T cells.
    Permanyer M; Ballana E; Badia R; Pauls E; Clotet B; Esté JA
    J Biol Chem; 2012 Sep; 287(38):32017-26. PubMed ID: 22846998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of clathrin-mediated endocytosis in human immunodeficiency virus type 1 entry.
    Daecke J; Fackler OT; Dittmar MT; Kräusslich HG
    J Virol; 2005 Feb; 79(3):1581-94. PubMed ID: 15650184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infectious HIV-1 assembles in late endosomes in primary macrophages.
    Pelchen-Matthews A; Kramer B; Marsh M
    J Cell Biol; 2003 Aug; 162(3):443-55. PubMed ID: 12885763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 gp41: mediator of fusion and target for inhibition.
    Weiss CD
    AIDS Rev; 2003; 5(4):214-21. PubMed ID: 15012000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of HIV-1 virions or gp120-anti-gp120 immune complexes to HIV-1-infected quiescent peripheral blood mononuclear cells reveals latent infection.
    Briant L; Coudronnière N; Robert-Hebmann V; Benkirane M; Devaux C
    J Immunol; 1996 May; 156(10):3994-4004. PubMed ID: 8621941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4- and dynamin-dependent endocytosis of HIV-1 into plasmacytoid dendritic cells.
    Pritschet K; Donhauser N; Schuster P; Ries M; Haupt S; Kittan NA; Korn K; Pöhlmann S; Holland G; Bannert N; Bogner E; Schmidt B
    Virology; 2012 Feb; 423(2):152-64. PubMed ID: 22209232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-to-cell transfer of HIV-1 via virological synapses leads to endosomal virion maturation that activates viral membrane fusion.
    Dale BM; McNerney GP; Thompson DL; Hubner W; de Los Reyes K; Chuang FY; Huser T; Chen BK
    Cell Host Microbe; 2011 Dec; 10(6):551-62. PubMed ID: 22177560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly potent inhibition of human immunodeficiency virus type 1 replication by TAK-220, an orally bioavailable small-molecule CCR5 antagonist.
    Takashima K; Miyake H; Kanzaki N; Tagawa Y; Wang X; Sugihara Y; Iizawa Y; Baba M
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3474-82. PubMed ID: 16048963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Vpu-regulated endocytosis of HIV-1 Gag is clathrin-independent.
    Harila K; Salminen A; Prior I; Hinkula J; Suomalainen M
    Virology; 2007 Dec; 369(2):299-308. PubMed ID: 17822732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infectious entry of West Nile virus occurs through a clathrin-mediated endocytic pathway.
    Chu JJ; Ng ML
    J Virol; 2004 Oct; 78(19):10543-55. PubMed ID: 15367621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.